- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Shanghai Shyndec Pharmaceutical Co Ltd (600420)
Shanghai Shyndec Pharmaceutical Co Ltd stock price live, this page displays SS 600420 stock exchange data. View the 600420 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Shanghai Shyndec Pharmaceutical Co Ltd real time stock price chart below.
What Is the Shanghai Shyndec Pharmaceutical Co Ltd Stock Price Today?
The Shanghai Shyndec Pharmaceutical Co Ltd stock price today is 8.33.
What Is the Stock Symbol for Shanghai Shyndec Pharmaceutical Co Ltd?
The stock symbol for Shanghai Shyndec Pharmaceutical Co Ltd is "600420."
What Stock Exchange Does Shanghai Shyndec Pharmaceutical Co Ltd Trade On?
Shanghai Shyndec Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Shanghai Shyndec Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Shanghai Shyndec Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600420 quote. (ISIN: CNE000001JG2)
What Is the Shanghai Shyndec Pharmaceutical Co Ltd Stock Price Today?
The Shanghai Shyndec Pharmaceutical Co Ltd stock price today is 8.33.
What Is the Stock Symbol for Shanghai Shyndec Pharmaceutical Co Ltd?
The stock symbol for Shanghai Shyndec Pharmaceutical Co Ltd is "600420."
What Stock Exchange Does Shanghai Shyndec Pharmaceutical Co Ltd Trade On?
Shanghai Shyndec Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Shanghai Shyndec Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Shanghai Shyndec Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600420 quote. (ISIN: CNE000001JG2)
Shanghai
Currency in CNY
8.33
-0.07(-0.83%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.25
8.53
52 wk Range
7.67
11.09
Earnings results expected in 15 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.258.53
52 wk Range
7.6711.09
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600420 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 27, 2026
EPS / Forecast
0.10 / --
Revenue / Forecast
1.88B / --
Compare 600420 to Peers and Sector
Metrics to compare | 600420 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600420PeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.6x | 17.2x | −0.3x | |
PEG Ratio | −0.43 | 0.74 | 0.00 | |
Price/Book | 0.8x | 2.1x | 2.6x | |
Price / LTM Sales | 1.3x | 3.1x | 2.9x | |
Upside (Analyst Target) | - | 37.1% | 64.3% | |
Fair Value Upside | Unlock | 22.0% | 9.9% | Unlock |
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provides nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and cefoperazone dispersible tablets; and cefuroxime axetil tablets, cefuroxime sodium for injection, cefaclor extended-release capsules, cefixime granules, and cefdinir dispersible tablets. It also offers nifedipine controlled-release tablets, amlodipine besylate tablets, enalapril maleate tablet, pravastatin sodium tablets, olmesartan medoxomil hydrochlorothiazide tablets, olmesartan amlodipine tablets; milnaprom hydrochloride tablets, lofen codeine tablets, gastrodin injection, naloxone hydrochloride injection, piracetam injection; and apmis film, tacrolimus capsules, mannan peptide for injection, imatinib mesylate. In addition, the company provides methylprednisolone sodium succinate for injection, octreotide acetate injection, betamethasone sodium phosphate for injection, dexamethasone sodium phosphate injection; diclofenac sodium sustained release tablets; 6-aminopenicillinic acid, azithromycin, amoxicillin, potassium clavulanate microcrystalline cellulose, ceftriaxone sodium crude salt, 7-aminocephalosporanic acid, chorionic gonadotropin, urinary gonadotropin; and naphazoline hydrochloride nasal drops, Ambroxol Hydrochloride Oral Solution. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 1996 and is based in Shanghai, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Shyndec (600420) Stock Price Today?
The Shyndec stock price today is 8.33 CNY.
What Stock Exchange Does Shyndec Trade On?
Shyndec is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Shyndec?
The stock symbol for Shyndec is "600420."
Does Shyndec Pay Dividends? What’s The Current Dividend Yield?
The Shyndec dividend yield is 3.0%%.
What Is the Shyndec Market Cap?
As of today, Shyndec market cap is 11.17B CNY.
What Is Shyndec's Earnings Per Share (TTM)?
The Shyndec EPS (TTM) is 0.41.
When Is the Next Shyndec Earnings Date?
Shyndec will release its next earnings report on Oct 31, 2026.
From a Technical Analysis Perspective, Is 600420 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Shyndec Stock Split?
Shyndec has split 5 times.
How Many Employees Does Shyndec Have?
Shyndec has 9697 employees.
What is the current trading status of Shyndec (600420)?
As of Oct 16, 2026, Shyndec (600420) is trading at a price of 8.33 CNY, with a previous close of 8.33 CNY. The stock has fluctuated within a day range of 8.25 CNY to 8.53 CNY, while its 52-week range spans from 7.67 CNY to 11.09 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.